Board of Directors

Chairman of the Board

Norton currently serves as the Founder and Executive Chairman of Doventi Capital. Norton has extensive experience at the senior management level of capital investments and has been involved in several large acquisitions, consolidations, and start-ups in Canada’s legal cannabis sector, both private and public. As an investor and advisor to numerous companies in Canada’s ACMPR sector, he has been responsible for deploying over C$35M into the legal cannabis sector and has been involved in another C$50M of public M&A ACMPR transactions. Norton was also an advisor to, and significant investor in, Invictus MD (IMH.V).

As an experienced corporate leader, he has facilitated in regulatory matters, corporate matters, raising capital privately and publicly, as well as strategic corporate development within the public markets.

Director

Michael formerly served as a Director of Invictus. He is also an advisor to Doventi Capital.  Michael holds degrees in Kinesiology and Geology from Simon Fraser University. As a venture capitalist, he has been involved since 2009 in the start-up and senior management of numerous public companies as well as performing the role of Consultant and Advisor. In his recent role as Director and Senior Executive of Invictus, Michael helped oversee the acquisition, management and growth of a diverse portfolio of cannabis-centric businesses owned by Invictus. These businesses include manufacturing hydroponic equipment, laboratory testing and services, cultivation, media, marketing and biopharmaceutical applications. Michael has been directly involved in raising more than C$65M of capital in the cannabis sector.

Independent non-executive director

Mr. Schreiber is a highly accomplished executive with deep experience in the global retail pharmacy, health, beauty sectors and Fast-Moving Consumer Goods (FMCG) business.  He has significant experience in the FMCG and multinational retail industry, including several senior leadership positions with Reckitt Benckiser,  CEO of Health and Beauty Europe, at A.S. Watson where he was responsible for 4000 stores in 23 countries, CEO and President of Shoppers Drug Mart (Pharmaprix in Quebec), CEO and President of Rexall Health, and most recently as CEO at Katz Group. He also served as the Chairman of the Board and Member at ALDO Group from 2017 to 2019, and previous to that, lead the Advisory Board from 2013 to 2017.

Independent non-executive director
Chair of the Compensation Committee

Aaron serves on the advisory board of Doventi Capital Fund II L.P. Aaron practices law as a solicitor at Farris, Vaughan, Wills & Murphy LLP in Kelowna. Aaron specializes in the areas of corporate and commercial law, real estate, bank lending, and wills and estates. Aaron holds an undergraduate degree in Science as well as a Law degree, both from the University of Victoria. He also currently sits on the Board of Directors of the Metro Up Financial Literacy Society and is a member of both the Canadian Bar Association and the Kelowna Bar Association.

Independent non-executive director
Chair of the Audit Committee

Derek is a partner at Spence Valuation Group, where he specializes in business valuation, mergers and acquisitions and financial litigation support. Prior to joining SVG, he worked for national firms in valuations, transaction advisory and audit roles, in London, Kelowna and Vancouver. Derek has extensive experience in the valuation of privately-held companies for purchase & sales transactions, shareholder disputes, corporate reorganizations and estate freezes. Derek is a Chartered Professional Accountant (CPA), a Chartered Business Valuator (CBV) and a Chartered Financial Analyst (CFA).